HPV

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

By

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

More Than 14 Million Preteens Need to Receive HPV Vaccine

More Than 14 Million Preteens Need to Receive HPV Vaccine

14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.

HPV Vaccination Decreases High-Grade Cervical Lesions in Women

HPV Vaccination Decreases High-Grade Cervical Lesions in Women

From 2008 to 2015, both cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ rates and cervical cancer screening declined in women age 18 to 24 years.

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every 3 years from age 21; different screening options from age 30 to 65.

Parental Influences on HPV Vaccination Among Low-Income Hispanic Adolescent Girls

Parental Influences on HPV Vaccination Among Low-Income Hispanic Adolescent Girls

By

Researchers sought to identify parental predictors of HIV vaccination in low-income adolescent Hispanic girls.

HPV Legislation Doesn't Impact Teen Sexual Behaviors

HPV Legislation Doesn't Impact Teen Sexual Behaviors

No substantive or significant associations between HPV legislation and adolescent sexual behaviors.

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

By

Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old

Less than a year following the initial direct-to-tumor vaccine injection, all treated tumors disappeared.

HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis

HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis

Use of primary HPV testing results in significantly lower odds of CIN3 compared with cytology testing

Older Adults Increasingly Have HPV+ Oropharyngeal Cancers

Older Adults Increasingly Have HPV+ Oropharyngeal Cancers

Regardless of age, favorable survival conferred by an HPV-positive tumor status

Provider Engagement With Hesitant Parents May Increase HPV Vaccination Rates

Provider Engagement With Hesitant Parents May Increase HPV Vaccination Rates

Investigators examined parental hesitancy when discussing human papillomavirus vaccination with providers.

Good Evidence That HPV Vaccines Protect Against Cervical Precancer

Good Evidence That HPV Vaccines Protect Against Cervical Precancer

High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years

Clinician HPV interventions facilitate adolescent HPV vaccination

Clinician HPV interventions facilitate adolescent HPV vaccination

Clinicians using communication training and fact sheets to inform adolescents about HPV, significantly increased vaccination initiation and completion rates among their patients.

Human papillomavirus in males

Human papillomavirus in males

The importance of male vaccination cannot be overemphasized, because the risk of male-to-female HPV transmission is significant.

HPV vaccine effective against genital warts in 2 doses

HPV vaccine effective against genital warts in 2 doses

The researchers found that 2 doses of the HPV vaccine were just as protective as 3 doses.

Nitrate inhalants (poppers) associated with increased virus-associated cancer risk in HIV-uninfected MSM

Nitrate inhalants (poppers) associated with increased virus-associated cancer risk in HIV-uninfected MSM

By

Among HIV-uninfected men aged 50 to 70, heavy popper use was associated with an increased risk of virus-associated cancer with causes linked to HPV, HHV-8, and Epstein-Barr virus.

HPV vaccine substantially reduces oral HPV risk

HPV vaccine substantially reduces oral HPV risk

The data suggest that the vaccine may be reducing the prevalence of those infections by as high as 100%.

Almost half of men and women under 60 in the US infected with HPV

Almost half of men and women under 60 in the US infected with HPV

However, the HPV vaccine has the potential to reverse the epidemic and prevent thousands of cancers in the United States each year.

HPV educational session may boost vaccination rates in high school students

HPV educational session may boost vaccination rates in high school students

By

The students improved their basic knowledge of HPV and understood the benefits of the HPV vaccine.

CDC approves HPV vaccine in 2 doses for preteens

CDC approves HPV vaccine in 2 doses for preteens

By

Children younger than 15 may be given 2 HPV vaccine doses instead of 3, and the shots should be spaced at least 6 months apart.

FDA approves new HPV test

FDA approves new HPV test

By

A new HPV screening test that uses cervical cells collected for a Pap test has been approved by the FDA.

Healthcare issues of the LGBT community: What the primary care clinician should know

Healthcare issues of the LGBT community: What the primary care clinician should know

A greater understanding of the healthcare issues specific to the lesbian, gay, bisexual, and transgender community may improve the quality of care.

HPV education key in college populations

HPV education key in college populations

By

College-aged students may benefit from continued education regarding the spread of HPV, especially oral transmission

Increased use of Gardasil 9 for HPV prevention would reduce cervical cancer rates, healthcare costs

Increased use of Gardasil 9 for HPV prevention would reduce cervical cancer rates, healthcare costs

By

The new vaccine protects against 9 types of HPV and 5 cancer-causing strains.

ASCO recommendations aim to increase HPV vaccination rates

ASCO recommendations aim to increase HPV vaccination rates

By

The American Society of Clinical Oncology has released its recommendations to help improve rates of HPV vaccination worldwide.

HPV prevalence declines since introduction of vaccine in young females

HPV prevalence declines since introduction of vaccine in young females

By

Data collected between 2009 and 2012 show a significant decline in cases of HPV in females aged 14-19 and 20-24.

Pap smears, HPV, and screening
 for cervical cancer


Pap smears, HPV, and screening
 for cervical cancer


Confusion surrounds the current screening recommendations and guidelines.

Male adolescents not receiving HPV vaccine with other inoculations

Male adolescents not receiving HPV vaccine with other inoculations

A variety of factors have led to low rates of teenage boys being vaccinated for the human papillomavirus (HPV), said a report published in Pediatrics.

Human papillomavirus vaccination not linked to increase in sexually transmitted infections in adolescent females 


Human papillomavirus vaccination not linked to increase in sexually transmitted infections in adolescent females 


By

The HPV vaccination is not associated with an increase in sexually transmitted infections in adolescent females, study results suggest. The vaccine is recommended for all children 11 to 12 years old.

One and two doses of HPV-16/18 vaccine as effective as three

One and two doses of HPV-16/18 vaccine as effective as three

By

The Cervarix vaccine may be as effective in one or two doses as it is with three.

Sign Up for Free e-newsletters